• Medidata Launches Diversity Program, HHS Extends Partnership to Develop Monoclonal Antibodies, Flatiron Renews FDA Collab

    Clinical Research News | Flatiron Health renewed its collaboration with the Oncology Center of Excellence (OCE) of the United States Food and Drug Administration (FDA) to jointly develop and implement specific research projects; Medidata launched a program to improve diversity, equity, and inclusion in clinical trials; The U.S. Department of Health and Human Services (HHS) announced new details of its agreement with Regeneron to extend its public-private partnership to develop life-saving monoclonal antibodies as part of Project NextGen enhancing our preparedness for COVID-19 strains and variants; and more.

    Sep 28, 2023
  • Follow the Money: NCI Awards Grant For Prostate Cancer Treatment Study, Recruiting Participants For Immunotherapy Drug Trials

    Clinical Research News | The Icahn School of Medicine at Mount Sinai nets a grant to identify the best prostate cancer treatment for people with HIV; EverImmune will conduct a phase I/II clinical trial for its drug candidate Oncobax AK in patients undergoing immunotherapy; NIH establishes the Multi-Omics for Health and Disease Consortium to advance the generation and analysis of “multi-omic” data for human health research; more.

    Sep 27, 2023
  • Proteomics-Based Assays To Enable Precision Medicine For Ovarian Cancer

    Clinical Research News | Over 900 genes have been implicated in the resistance of tumors to platinum-based chemotherapy that map to many different cellular pathways, thwarting efforts to identify a biomarker to predict refractoriness.

    Sep 26, 2023